Abstract. Hypertension and diabetes mellitus are important risk factors for myocardial infarction (MI). The purpose of the present study was to identify genetic variants that confer susceptibility to MI in individuals with or without hypertension or diabetes mellitus, thereby contributing to the personalized prevention of MI in such individuals. The study population comprised 5,835 unrelated Japanese individuals, including 1,339 subjects with MI and 4,496 controls. The 150 polymorphisms were selected by genome-wide association studies of MI and ischemic stroke with the use of the GeneChip Human Mapping 500K Array Set. The genotypes for these polymorphisms were determined by a method that combines the polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology. The chi-square test, multivariable logistic regression analysis with adjustment for covariates, as well as a stepwise forward selection procedure revealed that three different polymorphisms were significantly (P<0.005) associated with the prevalence of MI in individuals with or without hypertension or diabetes mellitus: the C→T polymorphism of CLEC16A (rs9925481) in individuals without hypertension, the A→G polymorphism of SEMA3F (rs12632110) in individuals without diabetes mellitus and the A→G polymorphism of ALOX5 (rs7913948) in individuals without hypertension or diabetes mellitus. No polymorphism was significantly associated with MI in individuals with hypertension, in those with diabetes mellitus, or in those with both conditions. Stratification of subjects based on hypertension or diabetes mellitus may thus be important in order to achieve personalized prevention of MI with the use of genetic information.
Introduction
Myocardial infarction (MI) is a multifactorial disorder that is thought to result from an interaction between genetic background and environmental factors. Disease prevention is an important strategy for reducing the overall burden of MI, and the identification of markers for disease risk is essential both for risk prediction and for potential intervention to reduce the chance of future events.
Although genetic linkage analyses and association studies have implicated several loci and various candidate genes in predisposition to MI (1) , the genes that contribute to genetic susceptibility to MI remain to be identified definitively. We previously showed that genetic variants that confer susceptibility to MI differ between men and women (2, 3) , between individuals with or without conventional risk factors for atherosclerosis (4) , or between individuals with different lipid profiles (5) . To further examine whether the association of polymorphisms with MI is influenced by the absence or presence of hypertension or diabetes mellitus, we performed an association study for 150 polymorphisms of 144 candidate genes and MI in 5,835 Japanese individuals with or without hypertension or diabetes mellitus. The purpose of the present study was to identify genetic variants that confer susceptibility 
Association of genetic variants with myocardial infarction in individuals with or without hypertension or diabetes mellitus
Selection of polymorphisms. A total of 150 polymorphisms (data not shown) were selected by genome-wide association studies of MI and ischemic stroke (P-value for allele frequency <1.0x10 -7 ) with the use of the GeneChip Human Mapping 500K Array Set (Affymetrix, Santa Clara, CA) (6). We have Table I . Primers, probes, and other conditions for genotyping of polymorphisms related (P for allele frequency of <0.005) to myocardial infarction.
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not examined the relation of these polymorphisms to MI in our previous studies (2, 3, 7) .
Genotyping of polymorphisms. Venous blood (7 ml) was collected into tubes containing 50 mmol/l ethylenediaminetetraacetic acid (disodium salt), and genomic DNA was isolated with a kit (Genomix; Talent, Trieste, Italy). Genotypes of the 150 polymorphisms were determined at G&G Science (Fukushima, Japan) by a method that combines the polymerase chain reaction and sequence-specific oligonucleotide probes with suspension array technology (Luminex, Austin, TX). Primers, probes, and other conditions for genotyping of polymorphisms significantly associated with MI are shown in Table I . Detailed genotyping methodology was described previously (8) .
Statistical analysis. Quantitative data were compared between subjects with MI and controls by the unpaired Student's t-test. Categorical data were compared by the chisquare test. Allele frequencies were estimated by the gene 
Numbers in parentheses are percentages. SNP, single nucleotide polymorphism.
- 
Results
Genetic variants associated with MI in individuals with or without hypertension.
The characteristics of the subjects with or without hypertension are shown in Table II . For individuals with hypertension, the frequency of male subjects, serum concentrations of triglycerides, low density lipoprotein (LDL)-cholesterol and creatinine, fasting plasma glucose level, blood glycosylated hemoglobin content, and the prevalence of hypercholesterolemia and diabetes mellitus were greater, whereas age, diastolic blood pressure, serum concentration of high density lipoprotein (HDL)-cholesterol were lower, in subjects with MI than in controls. For individuals without hypertension, the frequency of male subjects, BMI, serum concentrations of triglycerides, LDL-cholesterol and creatinine, fasting plasma glucose level, blood glycosylated hemoglobin content, and the prevalence of diabetes mellitus were greater, whereas age, systolic and diastolic blood pressure, serum concentration of HDL-cholesterol were lower, in subjects with MI than in controls.
Comparison of allele frequencies with the chi-square test revealed that one or two polymorphisms were significantly (P<0.005) associated with MI in individuals with or without hypertension, respectively (Table III) . Multivariable logistic regression analysis with adjustment for age, sex, BMI, smoking Table IV . Multivariable logistic regression analysis of SNPs significantly (P-value for allele frequency <0.005) associated with myocardial infarction by the chi-square test among individuals with or without hypertension. 
OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, body mass index, smoking status, serum concentration of creatinine, and the prevalence of diabetes mellitus and hypercholesterolemia. P-values of <0.005 are shown in bold.
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status, serum concentration of creatinine, and the prevalence of diabetes mellitus and hypercholesterolemia revealed that the C➝T polymorphism of CLEC16A (dominant and additive 1 models) was significantly (P<0.005) associated with MI in individuals without hypertension (Table IV) . No polymorphism was significantly related to MI in individuals with hypertension. A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphism associated with MI by the chi-square test as well as of age, sex, BMI, smoking status, serum concentration of creatinine, and the prevalence of diabetes mellitus and hypercholesterolemia on MI (data not shown). For individuals with hypertension, sex, diabetes mellitus, serum concentration of creatinine, and DNAJC6 genotype (dominant model), in descending order of statistical significance, were significant (P<0.005) and independent determinants of MI. For individuals without hypertension, sex, diabetes mellitus, smoking, BMI, and CLEC16A genotype (dominant model), in descending order of statistical significance, were significant and independent determinants of MI.
Genetic variants associated with MI in individuals with or without diabetes mellitus.
The characteristics of the subjects with or without diabetes mellitus are shown in Table V . For individuals with diabetes mellitus, the frequency of male subjects, BMI, the percentage of smokers, serum concentrations Table V . Characteristics of subjects with myocardial infarction (MI) and controls among individuals with or without diabetes mellitus. 
Quantitative data are means ±SD. LDL, low density lipoprotein; HDL, high density lipoprotein.
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of LDL-cholesterol and creatinine, blood glycosylated hemoglobin content were greater, whereas age, diastolic blood pressure, serum concentration of HDL-cholesterol were lower, in subjects with MI than in controls. For individuals without diabetes mellitus, the frequency of male subject, serum concentrations of triglycerides, LDL-cholesterol, and creatinine, blood glycosylated hemoglobin content, and the prevalence of hypertension were greater, whereas age, diastolic blood pressure, serum concentration of HDL-cholesterol were lower, in subjects with MI than in controls.
Comparison of allele frequencies with the chi-square test revealed that one different polymorphism was significantly (P<0.005) associated with MI in individuals with or without diabetes mellitus, respectively (Table VI) . Multivariable logistic regression analysis with adjustment for age, sex, BMI, smoking status, serum concentration of creatinine, and the prevalence of hypertension and hypercholesterolemia revealed that the A➝G polymorphism of SEMA3F (dominant model) was significantly (P<0.005) associated with MI in individuals without diabetes mellitus (Table VII) . No polymorphism was significantly related to MI in individuals with diabetes mellitus.
A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphism associated with MI by the chi-square test as well as of age, sex, BMI, smoking status, serum concentration of creatinine, and the prevalence of hypertension and hypercholesterolemia on MI (data not shown). For individuals with diabetes mellitus, sex was a significant (P<0.005) and independent determinant of MI. For individuals without diabetes mellitus, sex, hypertension, smoking, serum concentration of creatinine, and SEMA3F genotype (dominant model), in descending order of statistical significance, were significant (P<0.005) and independent determinants of MI.
Genetic variants associated with MI in individuals with hypertension and diabetes mellitus or without these conditions.
The characteristics of the subjects with hypertension and diabetes mellitus or without these conditions are shown in Table VIII . For individuals with hypertension and diabetes mellitus, the frequency of male subjects, BMI, the percentage of smokers, fasting plasma glucose level, serum concentration of creatinine were greater, whereas age, diastolic blood pressure, serum concentration of HDL-cholesterol, and the prevalence of hypercholesterolemia were lower, in subjects with MI than in controls. For individuals without hypertension or diabetes mellitus, the frequency of male subjects, serum concentrations of triglycerides and creatinine, and blood glycosylated hemoglobin content were greater, whereas systolic and diastolic blood pressure, and the serum concentration of HDLcholesterol were lower, in subjects with MI than in controls.
Comparison of allele frequencies with the chi-square test revealed that two polymorphisms were significantly (P<0.005) associated with MI in individuals without hypertension or diabetes mellitus (Table IX) . No polymorphism was significantly related to MI in individuals with hypertension and diabetes mellitus. Multivariable logistic regression analysis with adjustment for age, sex, BMI, smoking status, serum concentration of creatinine, and the prevalence of hypercholesterolemia revealed that the A➝G polymorphism of ALOX5 (recessive model) was significantly (P<0.005) Table VII . Multivariable logistic regression analysis of SNPs significantly (P-value for allele frequency <0.005) associated with myocardial infarction by the chi-square test among individuals with or without diabetes mellitus.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, body mass index, smoking status, serum concentration of creatinine, and the prevalence of hypertension and hypercholesterolemia. P-values of <0.005 are shown in bold.
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associated with MI in individuals without hypertension or diabetes mellitus (Table X) . A stepwise forward selection procedure was performed to examine the effects of genotypes for the polymorphism associated with MI by the chi-square test as well as of age, sex, BMI, smoking status, serum concentration of creatinine, and the prevalence of hypercholesterolemia on MI (data not shown). For individuals without hypertension or diabetes mellitus, sex, smoking, ALOX5 genotype (recessive model), and CLEC16A genotype (dominant model), in descending order of statistical significance, were significant (P<0.005) and independent determinants of MI.
Finally, we examined whether the genotype distributions for the polymorphisms associated with MI were in HardyWeinberg equilibrium. The genotype distributions for the C➝T polymorphism of CLEC16A in individuals without hypertension, the A➝G polymorphism of SEMA3F in individuals without diabetes mellitus, and the A➝G polymorphism of ALOX5 in individuals without hypertension or diabetes mellitus were all in Hardy-Weinberg equilibrium both in subjects with MI and in controls (data not shown).
Discussion
We examined the possible relations of 150 polymorphisms of 144 genes to the prevalence of MI in individuals with or without hypertension or diabetes mellitus. Our association study with three steps of analysis (chi-square test, multivariable logistic regression analysis, and stepwise forward selection procedure) revealed that three different polymorphisms were significantly associated with MI: the C➝T polymorphism of CLEC16A (rs9925481) in individuals Table VIII . Characteristics of subjects with myocardial infarction (MI) and controls among individuals with hypertension and diabetes mellitus or without these conditions.
-----------------------------------------------------------------------------------------------------With hypertension and diabetes mellitus
Without hypertension or diabetes mellitus 
- Table IX . Genotype distributions of SNPs significantly (P-value for allele frequency <0.005) associated with myocardial infarction (MI) among individuals without hypertension or diabetes mellitus as determined by the chi-square test. 
without hypertension, the A➝G polymorphism of SEMA3F (rs12632110) in individuals without diabetes mellitus, and the A➝G polymorphism of ALOX5 (rs7913948) in individuals without hypertension or diabetes mellitus. Our results suggest that genetic variants that confer susceptibility to MI differed among individuals with or without hypertension or diabetes mellitus and that genetic component for the development of MI was more apparent in individuals at low-risk than in those at high-risk. The C-type lectin domain family 16, member A (CLEC16A) was shown to be highly expressed in B lymphocytes and natural killer and dendritic cells (9) . The G allele of the G➝A polymorphism of CLEC16A (rs2903692) was related to an increased risk for type 1 diabetes mellitus in Japanese subjects (10) , as well as in white populations (11, 12) . Three common non-coding variants of CLEC16A (rs2903692, rs725613, and rs17673553), which were in strong linkage disequilibrium, were significantly associated with type 1 diabetes mellitus in a genome-wide association study (12) . These results indicate that CLEC16A is involved in the pathogenesis of type 1 diabetes mellitus. We have now shown that C➝T polymorphism of CLEC16A (rs9925481) was significantly associated with MI in individuals without hypertension, with the T allele protecting against this condition, although the mechanism responsible for this association remains to be elucidated.
Sema, immunoglobulin and short basic domains, secreted, 3F (SEMA3F) is a secreted member of the semaphorin III family. During the developmental process, SEMA3F plays a pivotal role in axon guidance in the peripheral and central nervous system by interacting with its receptor, neuropilin 2 (NRP2) (13) . The SEMA3F-NRP2 signaling pathway guides axonal extension by means of a chemotactic repulsing effect on the axons (14) . SEMA3F was isolated from a region of 3p21.3 involved in homozygous deletions in small cell lung cancer cell lines and was recognized as a candidate tumor suppressor gene, given that p53 inhibits tumor vessel formation and cell growth through the SEMA3F-NRP2 pathway (15) . We have now shown that the A➝G polymorphism of SEMA3F (rs12632110) was significantly associated with MI in individuals without diabetes mellitus, with the G allele protecting against this condition, although the underlying mechanism remains unclear.
Arachidonate 5-lipoxygenase (ALOX5) is the key enzyme in the oxdative biosynthesis of leukotrienes (16) . The ALOX5 pathway has been related to atherosclerosis in mouse models (17, 18) and, in a histological study, in humans (19) . There is a tandem repeat polymorphism in the promoter of ALOX5. The common allele has five tandem 5'-GGGCGG-3' repeats (20) , while the variant allele has fewer or greater number of repeats. In a cohort of 470 middle-aged men and women without overt cardiovascular disease, mean carotid intimamedia thickness (IMT) was increased among carriers of two variant alleles, as compared to subjects carrying at least one common allele (20) . Given that increased carotid IMT is a marker of systemic atherosclerosis (21) and is a predictor of future CHD (22) , these observations implicate ALOX5 as a candidate gene for CHD. We have now shown that the A➝G polymorphism of ALOX5 (rs7913948) was significantly associated with the prevalence of MI in individuals without Table X . Multivariable logistic regression analysis of SNPs significantly (P value for allele frequency < 0.005) associated with myocardial infarction by the chi-square test among individuals without hypertension or diabetes mellitus.
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OR, odds ratio; CI, confidence interval. Multivariable logistic regression analysis was performed with adjustment for age, sex, body mass index, smoking status, serum concentration of creatinine, and the prevalence of hypercholesterolemia. P values of < 0.005 are shown in bold.
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hypertension or diabetes mellitus, with the G allele representing a risk factor for this condition. Effects of this polymorphism on the development of atherosclerosis may account for its association with MI. Our study has limitations: (i) it is possible that one or more of the polymorphisms associated with MI in the present study are in linkage disequilibrium with other polymorphisms in the same gene or in other nearby genes that are actually responsible for the development of this condition, (ii) although we adopted the criterion of P<0.005 for association to compensate for the multiple comparisons of genotypes with MI, it is not possible to exclude completely potential statistical errors such as false positives, (iii) the functional relevance of the identified polymorphisms to gene transcription or to protein structure or function was not determined in the present study.
In conclusion, genetic variants that confer susceptibility to MI differed among individuals with or without hypertension or diabetes mellitus. Stratification of subjects based on hypertension or diabetes mellitus may thus be important in order to achieve personalized prevention of MI with the use of genetic information. Given that our present study may be considered as hypothesis generating, validation of our findings will require their replication with independent subject panels.
